Beclometasone
Also known as: Beclometasone dipropionate Beclomethasone dipropionate
Brand names: AEROCORTIN BECLAZONE BECLOMET BECONASE CANDID-B (in combination) CLENIL DECOMIT FORMODUAL (in combination) FOSTER (in combination) MENADERM (in combination) PROPADERM QNASL QVAR RIARIFY (in combination) RINOSOL SABACOMB (in combination) TRIMBOW (in combination) TRYDONIS (in combination)
Therapeutic Indications
Beclometasone is indicated for:
Prophylactic management of mild, moderate or severe asthma
Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old)
Beclometasone is indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children:
Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis.
Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone.
Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Respiratory (Inhalation) - 200-400 ug in two divided doses
Ulcerative colitis
Irrespective of gender only Adults (18 - 65 years old)
Beclometasone is indicated for the treatment of mild or moderate ulcerative colitis in active phase, as add-on therapy to 5-ASA containing drugs in patients who are non-responders to 5-ASA therapy in active phase.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 5mg once a day
Prophylactic management of mild, moderate or severe asthma
Irrespective of gender only Adults (18 years old or older)
Beclometasone is indicated for the prophylactic management of mild, moderate, or severe asthma in adults or children:
Mild asthma: Patients requiring intermittent symptomatic bronchodilator asthma medication on a regular basis.
Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone.
Severe asthma: Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Respiratory (Inhalation) - 400-800 ug in two divided doses
Contraindications
Active ingredient Beclometasone is contraindicated in the following cases:
Mycosis
No gender/age discrimination
Viral infection
No gender/age discrimination
Tuberculosis
No gender/age discrimination